alexa Acinetobacter baumannii

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Acinetobacter baumannii

Acinetobacter baumannii, a ubiquitous aerobic Gram-negative bacterium with high propensity to multi-drug resistance is a worldwide concern because of its dramatic increase over the past few decades, particularly in the setting of intensive care unit. The continuing debate surrounds the question of whether it is simply colonization with little clinical relevance or requires eradication because of its potential pathogenicity.In the obvious cases of active infection, such as overt pneumonia or multiple sites isolation especially from blood of A. baumannii, the decision to treat A. baumannii is usually straightforward. The dilemma occurs when A. baumannii is being isolated in the respiratory specimens of patients lacking evidence of active or ongoing lung infections, normally considered as a colonization that does not require eradication.

Citation: Loh LC, Yii CTJ, Tong JMG (2012) Saps II-Predicted Mortality in Ventilated Patients with Respiratory Acinetobacter baumannii Alone vs. Negative Culture. J Medical Microbiol Diagnosis 1:105

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top